Vinicius Bonatto

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Efficacy, Structure-Activity Relationship, and Mode of Action Studies of a New Generation of Acridine/Acridone-Based Antimalarials.

Efficacy, Structure-Activity Relationship, and Mode of Action Studies of a New Generation of Acridine/Acridone-Based Antimalarials.

Journal: ACS infectious diseases

Published: May 26, 2026

Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance.

Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance.

Journal: Research square

Published: November 24, 2025

Fluorescent Marinoquinoline Derivative as Inhibitors of Plasmodium falciparum: SAR Analysis, Mode of Action and In Vivo Studies.

Fluorescent Marinoquinoline Derivative as Inhibitors of Plasmodium falciparum: SAR Analysis, Mode of Action and In Vivo Studies.

Journal: Journal of medicinal chemistry

Published: September 30, 2025

Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance.

Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance.

Journal: Nature communications

Published: September 23, 2025

Exploring Nirmatrelvir Derivatives Through P2 Substituent Modifications and Warhead Innovations Targeting the Main Protease of SARS-CoV-2.

Exploring Nirmatrelvir Derivatives Through P2 Substituent Modifications and Warhead Innovations Targeting the Main Protease of SARS-CoV-2.

Journal: Archiv der Pharmazie

Published: September 04, 2025

Evaluating the protonation state of the catalytic Cys25 in cruzain cysteine protease: A target for Chagas disease.

Evaluating the protonation state of the catalytic Cys25 in cruzain cysteine protease: A target for Chagas disease.

Journal: Protein science : a publication of the Protein Society

Published: April 30, 2025

Tandem Mass Spectrometry and Bio-Guided Isolation of Secondary Metabolites With Antiplasmodial Activity From Dalbergia miscolobium Bark.

Tandem Mass Spectrometry and Bio-Guided Isolation of Secondary Metabolites With Antiplasmodial Activity From Dalbergia miscolobium Bark.

Journal: Chemistry & biodiversity

Published: April 27, 2025

Marine Guanidine Alkaloids Inhibit Malaria Parasites Development in In Vitro, In Vivo and Ex Vivo Assays.

Marine Guanidine Alkaloids Inhibit Malaria Parasites Development in In Vitro, In Vivo and Ex Vivo Assays.

Journal: ACS infectious diseases

Published: April 15, 2025

Novel selective proline-based peptidomimetics for human cathepsin K inhibition.

Novel selective proline-based peptidomimetics for human cathepsin K inhibition.

Journal: Bioorganic & medicinal chemistry letters

Published: May 14, 2024

Nitriles: an attractive approach to the development of covalent inhibitors.

Nitriles: an attractive approach to the development of covalent inhibitors.

Journal: RSC medicinal chemistry

Published: July 01, 2022

A patent review on cathepsin K inhibitors to treat osteoporosis (2011 - 2021).

A patent review on cathepsin K inhibitors to treat osteoporosis (2011 - 2021).

Journal: Expert opinion on therapeutic patents

Published: February 09, 2022

Predicting the Relative Binding Affinity for Reversible Covalent Inhibitors by Free Energy Perturbation Calculations.

Predicting the Relative Binding Affinity for Reversible Covalent Inhibitors by Free Energy Perturbation Calculations.

Journal: Journal of chemical information and modeling

Published: August 30, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026